• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新的细胞坏死签名预测肺腺癌患者的生存。

A novel necroptosis signature for predicting survival in lung adenocarcinoma.

机构信息

Department of ICU, the Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Jiangsu Province, Huai'an, No.1, Huanghe West Road, Huaiyin District, 223300, China.

出版信息

BMC Med Genomics. 2023 Nov 28;16(1):305. doi: 10.1186/s12920-023-01748-9.

DOI:10.1186/s12920-023-01748-9
PMID:38017445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10685572/
Abstract

BACKGROUND

To explore the necroptosis-related genes (NRGs) signature and its predictive values in lung adenocarcinoma (LUAD).

METHODS

The training cohort consisted of tumor samples from The Cancer Genome Atlas, and the validation set comprised data from the Gene Expression Omnibus. Univariate and multivariate Cox regression analyses were applied to identify the prognostic NRG signature as an independent molecular indicator. Correlation analysis was used for the association assessment between the NRG signature and immune checkpoint molecules.

RESULTS

NRGs involved in necroptosis and immune NOD-like receptor signaling. The NRG signature based on eight NRGs can divide tumors into high-risk and low-risk groups, which was significantly associated with worse survival. Multivariate Cox regression analysis showed that this NRG signature remained an independent prognostic indicator. Stratification analyses demonstrated that this NRG signature was still effective for predicting survival in each stratum of age, gender, and tumor stage. The ROC curve showed a good predictive ability using the NRG signature in the validation cohort (AUC = 0.81). The NRG signature was related to immune checkpoint molecules PD - 1, PD-L1, and PD-L2.

CONCLUSIONS

The NRG signature could be a novel predictor of the prognosis and may become a potential therapeutic target in LUAD.

摘要

背景

探索肺腺癌(LUAD)中与坏死性凋亡相关的基因(NRGs)特征及其预测价值。

方法

训练队列由癌症基因组图谱中的肿瘤样本组成,验证集包含来自基因表达综合数据库的数据。应用单因素和多因素 Cox 回归分析来确定作为独立分子指标的预后 NRG 特征。采用相关性分析评估 NRG 特征与免疫检查点分子之间的关联。

结果

NRGs 涉及坏死性凋亡和免疫 NOD 样受体信号转导。基于 8 个 NRGs 的 NRG 特征可将肿瘤分为高风险和低风险组,与生存不良显著相关。多因素 Cox 回归分析表明,该 NRG 特征仍然是独立的预后指标。分层分析表明,该 NRG 特征在年龄、性别和肿瘤分期的每个亚层中仍然可以有效地预测生存。验证队列中的 ROC 曲线显示 NRG 特征具有良好的预测能力(AUC=0.81)。NRG 特征与免疫检查点分子 PD-1、PD-L1 和 PD-L2 相关。

结论

NRG 特征可以作为 LUAD 预后的新预测因子,并可能成为潜在的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f1b/10685572/b867b60bedbe/12920_2023_1748_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f1b/10685572/e8bc6123a28a/12920_2023_1748_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f1b/10685572/bd00e486e5eb/12920_2023_1748_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f1b/10685572/6aea2184d124/12920_2023_1748_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f1b/10685572/6886b2c95707/12920_2023_1748_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f1b/10685572/cfee5f168cd8/12920_2023_1748_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f1b/10685572/b867b60bedbe/12920_2023_1748_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f1b/10685572/e8bc6123a28a/12920_2023_1748_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f1b/10685572/bd00e486e5eb/12920_2023_1748_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f1b/10685572/6aea2184d124/12920_2023_1748_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f1b/10685572/6886b2c95707/12920_2023_1748_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f1b/10685572/cfee5f168cd8/12920_2023_1748_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f1b/10685572/b867b60bedbe/12920_2023_1748_Fig6_HTML.jpg

相似文献

1
A novel necroptosis signature for predicting survival in lung adenocarcinoma.一种新的细胞坏死签名预测肺腺癌患者的生存。
BMC Med Genomics. 2023 Nov 28;16(1):305. doi: 10.1186/s12920-023-01748-9.
2
Identification of a necroptosis-related gene signature for making clinical predictions of the survival of patients with lung adenocarcinoma.鉴定一个与细胞坏死性凋亡相关的基因特征,用于对肺腺癌患者的生存进行临床预测。
PeerJ. 2024 Jan 8;12:e16616. doi: 10.7717/peerj.16616. eCollection 2024.
3
Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.鉴定与宫颈癌肿瘤免疫微环境相关的坏死性凋亡相关预后基因特征,并进行实验验证。
World J Surg Oncol. 2022 Oct 17;20(1):342. doi: 10.1186/s12957-022-02802-z.
4
A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma.一种新型坏死性凋亡相关lncRNA特征预测肺腺癌预后
Front Genet. 2022 Mar 17;13:862741. doi: 10.3389/fgene.2022.862741. eCollection 2022.
5
A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma.肺腺癌中用于生存预测和免疫检查点分子的新型免疫特征。
J Transl Med. 2020 Mar 6;18(1):123. doi: 10.1186/s12967-020-02286-z.
6
Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma.鉴定一个与坏死性凋亡相关的基因特征作为胆管癌的一个新的预后生物标志物。
Front Immunol. 2023 Mar 2;14:1118816. doi: 10.3389/fimmu.2023.1118816. eCollection 2023.
7
Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.早期肺腺癌中一种稳健的免疫相关预后标志物的开发与验证
J Transl Med. 2020 Oct 7;18(1):380. doi: 10.1186/s12967-020-02545-z.
8
Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.食管癌中坏死性凋亡相关预后基因特征的鉴定和验证及肿瘤免疫微环境浸润特征分析。
BMC Gastroenterol. 2022 Jul 15;22(1):344. doi: 10.1186/s12876-022-02423-6.
9
Exploration and validation of a novel signature of seven necroptosis-related genes to improve the clinical outcome of hepatocellular carcinoma.探索和验证七个坏死性凋亡相关基因的新型标志物,以改善肝细胞癌的临床预后。
BMC Cancer. 2023 Oct 24;23(1):1029. doi: 10.1186/s12885-023-11521-x.
10
Development and clinical validation of a necroptosis-related gene signature for prediction of prognosis and tumor immunity in lung adenocarcinoma.用于预测肺腺癌预后和肿瘤免疫的坏死性凋亡相关基因特征的开发与临床验证
Am J Cancer Res. 2022 Nov 15;12(11):5160-5182. eCollection 2022.